We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Century Casinos
CNTY
$32.9M
| $363K | ﹤0.01% |
49,577
+6,948
| +16% | +$58K |
|
2202
Omega Flex
OFLX
$292M
| $362K | ﹤0.01% |
+3,249
| New | +$352K |
|
2203
Progress Software
PRGS
$1.75B
| $362K | ﹤0.01% |
+6,300
| New | +$351K |
|
2204
Mine Safety
MSA
$6.79B
| $362K | ﹤0.01% |
+2,709
| New | +$365K |
|
2205
Beyond Air
XAIR
$3.97M
| $360K | ﹤0.01% |
133
+49
| +58% | +$125K |
|
|
OPFI.WS
2206
CALL
DELISTED
OppFi Inc Warrants
OPFI.WS
| $359K | ﹤0.01% |
175,000
| – | – |
|
2207
CapForce IBD 50 ETF
FFTY
$78.8M
| $359K | ﹤0.01% |
15,171
+300
| +2% | +$6.89K |
|
2208
Invesco KBW Property & Casualty Insurance ETF
KBWP
$276M
| $358K | ﹤0.01% |
+4,300
| New | +$375K |
|
2209
PUT
Intuit
INTU
$91.1B
| $357K | ﹤0.01% |
800
-9,500
| -92% | -$3.9M |
|
2210
C4 Therapeutics
CCCC
$389M
| $356K | ﹤0.01% |
+113,236
| New | +$667K |
|
|
ALLK
2211
DELISTED
Allakos
ALLK
| $355K | ﹤0.01% |
79,818
+24,036
| +43% | +$154K |
|
|
FFWM
2212
DELISTED
First Foundation Inc
FFWM
| $353K | ﹤0.01% |
47,321
-64,929
| -58% | -$867K |
|
|
NXDR
2213
Nextdoor Holdings
NXDR
$885M
| $352K | ﹤0.01% |
163,900
| – | – |
|
2214
Vera Therapeutics
VERA
$2.33B
| $348K | ﹤0.01% |
+44,786
| New | +$346K |
|
|
NFGC
2215
New Found Gold
NFGC
$526M
| $346K | ﹤0.01% |
69,100
+16,103
| +30% | +$63.9K |
|
2216
Fulcrum Therapeutics
FULC
$241M
| $345K | ﹤0.01% |
121,000
+105,474
| +679% | +$945K |
|
2217
First Internet Bancorp
INBK
$233M
| $344K | ﹤0.01% |
20,658
+2,302
| +13% | +$55.5K |
|
|
IMOS
2218
ChipMOS TECHNOLOGIES
IMOS
$1.59B
| $344K | ﹤0.01% |
13,696
-30,275
| -69% | -$708K |
|
2219
Medallion Financial
MFIN
$230M
| $343K | ﹤0.01% |
44,727
-23,476
| -34% | -$189K |
|
2220
Tejon Ranch
TRC
$460M
| $342K | ﹤0.01% |
+18,722
| New | +$360K |
|
2221
Bowman Consulting
BWMN
$454M
| $341K | ﹤0.01% |
+11,871
| New | +$311K |
|
2222
Healthpeak Properties
DOC
$15.5B
| $341K | ﹤0.01% |
+15,500
| New | +$384K |
|
|
AEON.WS
2223
CALL
DELISTED
AEON Biopharma Inc
AEON.WS
| $338K | ﹤0.01% |
33,315
-67,015
| -67% | -$3.87K |
|
2224
Triumph Financial Inc
TFIN
$1.81B
| $334K | ﹤0.01% |
5,756
-73,342
| -93% | -$4.21M |
|
2225
Biomea Fusion
BMEA
$88.2M
| $334K | ﹤0.01% |
10,776
-12,162
| -53% | -$151K |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.